Literature DB >> 20936534

Parvovirus-mediated fetal cardiomyopathy with atrioventricular nodal disease.

Shira G Fishman1, Linda M Pelaez, Rebecca N Baergen, Sheila J Carroll.   

Abstract

Acute parvovirus B19 infection (API) in pregnancy has been associated with fetal anemia and hydrops fetalis. Direct myocardial damage from API in a fetus and an infant has been described. This report presents a case of fetal second-degree heart block and cardiomyopathy secondary to API. A 19-year-old G4P1112 (gravida 4 para 2 with 1 term delivery, 1 preterm delivery, 1 termination, and 2 living children) was referred at 20 weeks gestation for fetal bradycardia. A 2:1 atrioventricular block was identified by fetal echocardiography at 23 weeks. Hydrops developed at 25 weeks. Amniocentesis and percutaneous umbilical blood sampling demonstrated API. At 31 weeks, the patient presented with preterm labor and delivered a viable female infant, who died of poor cardiac function and arrhythmia on the first day of life. In addition to fetal anemia and hydrops fetalis, API in pregnancy may cause direct fetal myocardial damage and conduction system disease.

Entities:  

Mesh:

Year:  2010        PMID: 20936534     DOI: 10.1007/s00246-010-9803-9

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  8 in total

1.  Use of terbutaline in the treatment of complete heart block in the fetus.

Authors:  B V Robinson; J A Ettedgui; F S Sherman
Journal:  Cardiol Young       Date:  2001-11       Impact factor: 1.093

Review 2.  Fetal parvovirus B19 infection.

Authors:  C S von Kaisenberg; W Jonat
Journal:  Ultrasound Obstet Gynecol       Date:  2001-09       Impact factor: 7.299

3.  Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant.

Authors:  Nikos Papadogiannakis; Thomas Tolfvenstam; Björn Fischler; Oscar Norbeck; Kristina Broliden
Journal:  Clin Infect Dis       Date:  2002-10-11       Impact factor: 9.079

Review 4.  Clinical aspects of parvovirus B19 infection.

Authors:  K Broliden; T Tolfvenstam; O Norbeck
Journal:  J Intern Med       Date:  2006-10       Impact factor: 8.989

Review 5.  Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review.

Authors:  G Nigro; V Bastianon; V Colloridi; F Ventriglia; P Gallo; G D'Amati; W C Koch; S P Adler
Journal:  Clin Infect Dis       Date:  2000-07-14       Impact factor: 9.079

6.  Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.

Authors:  Martin Enders; Andrea Weidner; Iris Zoellner; Karen Searle; Gisela Enders
Journal:  Prenat Diagn       Date:  2004-07       Impact factor: 3.050

7.  Atypical manifestations of congenital parvovirus B19 infection.

Authors:  Immacolata Savarese; Maria Pia De Carolis; Simonetta Costa; Gabriella De Rosa; Sara De Carolis; Serafina Lacerenza; Costantino Romagnoli
Journal:  Eur J Pediatr       Date:  2008-02-29       Impact factor: 3.183

8.  Three cases of myocarditis in childhood associated with human parvovirus (B19 virus).

Authors:  K Munro; M C Croxson; S Thomas; N J Wilson
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.838

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.